Purpose Contemporary, original research should be utilised to inform guidelines in urology relating to the COVID-19 pandemic. This comprehensive review aimed to: identify all up-to-date original publications relating to urology and COVID-19, characterise where publications were from, and outline what topics were investigated. Methods This review utilised a search strategy that assessed five electronic databases, additional grey literature, and global trial registries. All current published, in-press, and pre-print manuscripts were included. Eligible studies were required to be original research articles of any study design, reporting on COVID-19 or urology, in any of study population, intervention, comparison, or outcomes. Included studies were reported in a narrative synthesis format. Data were summarised according to primary reported outcome topic. A world heatmap was generated to represent where included studies originated from. Results Of the 6617 search results, 48 studies met final inclusion criteria, including 8 pre-prints and 7 ongoing studies from online registries. These studies originated from ten countries according to first author affiliation. Most studies originated from China ( n  = 13), followed by Italy ( n  = 12) and USA ( n  = 11). Topics of the study included pathophysiological, administrative, and clinical fields: translational ( n  = 14), COVID-19-related outcomes ( n  = 5), urology training ( n  = 4), telemedicine ( n  = 7), equipment and safety ( n  = 2), urology in general ( n  = 4), uro-oncology ( n  = 3), urolithiasis ( n  = 1), and kidney transplantation ( n  = 8). Conclusion This review has outlined available original research relevant to COVID-19 and urology from the international community. This summary may serve as a guide for future research priorities in this area.